
FINETRIAX-T 562.5 INJ.
Ceftriaxone 500 mg & Tazobactam 62.5 mg Injection
Product Specification
| Composition | Ceftriaxone 500 mg & Tazobactam 62.5 mg Injection |
|---|---|
| Dosage form | Injectable |
| Specification | In-house |
| Therapeutic category | Anti-Infectives & Antibiotics |
| Shelf life | 24 months |
| Pack | Vial with WFI 562.50GM Vial |
| Dossier | CTD / eCTD / ACTD dossier compilation provided on request |
| Registrations | Available on request |
Manufacturing & Quality:
Produced at Finecure's dedicated cephalosporin sterile injectables site, inspected to PIC/S GMP standards. Accreditations applicable to this line: WHO-GMP ? PIC/S GMP. Data integrity is maintained to 21 CFR Part 11, with electronic records and batch documentation logged, access-controlled and audit-ready.



